Literature DB >> 1406526

The Patient Self-Determination Act. Advance directives available to Minnesota patients.

D J McInerney1.   

Abstract

The Patient Self-Determination Act requires most health care institutions to inform patients of their right to refuse medical care and their right to provide advance direction regarding their wishes should they become incompetent. Although the PSDA does not apply to physicians, it will probably increase the demand for communication with patients on such matters. Patients will undoubtedly ask how to formulate advance directives. While physicians should make it clear that they are not providing legal advice to patients on such issues, they may wish to indicate that a guardianship and a living will are options available under Minnesota law. Additionally, as indicated above, a number of arguments exist that durable powers of attorney for health care are valid in Minnesota, as well. Physicians should familiarize themselves with living will forms and may wish to make them available to patients upon request. (Living will forms can be obtained by contacting the Minnesota Medical Association at 612/378-1875.) Patients with questions regarding durable powers of attorney should be advised to seek legal counsel.

Entities:  

Mesh:

Year:  1992        PMID: 1406526

Source DB:  PubMed          Journal:  Minn Med        ISSN: 0026-556X


  2 in total

1.  Qualitative assessment of the intention of Chinese community health workers to implement advance care planning using theory of planned behavior.

Authors:  Bingyu Xing; Guanmian Liang; Jing Zhang; Jinsheng Zhang; Zhizhi Jiang; Qunfang Miao
Journal:  BMC Palliat Care       Date:  2021-12-10       Impact factor: 3.234

2.  Barriers to advance care planning: a qualitative study of seriously ill Chinese patients and their families.

Authors:  Johnny T K Cheung; Doreen Au; Anthony H F Ip; Jenny Chan; Kenway Ng; Lok Cheung; Jacqueline Yuen; Elsie Hui; Jenny Lee; Raymond Lo; Jean Woo
Journal:  BMC Palliat Care       Date:  2020-06-08       Impact factor: 3.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.